Single User License
INR 169825
Site License
INR 339650
Corporate User License
INR 509475

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Meniere Disease Global Clinical Trials Review, H2

Meniere Disease Global Clinical Trials Review, H2


  Request for Sample Report

Executive Summary

Meniere Disease Global Clinical Trials Review, H2, 2015

GlobalData's clinical trial report, "Meniere Disease Global Clinical Trials Review, H2, 2015" provides an overview of Meniere Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Meniere Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Meniere Disease 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Clinical Trials by G7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 14

Clinical Trials by Phase in G7 Countries 15

Clinical Trials in G7 Countries by Trial Status 16

Clinical Trials by E7 Countries: Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials 17

Clinical Trials by Phase in E7 Countries 18

Clinical Trials by Phase 19

In Progress Trials by Phase 20

Clinical Trials by Trial Status 21

Clinical Trials by End Point Status 22

Unaccomplished Trials of Meniere Disease 23

Subjects Recruited Over a Period of Time 24

Clinical Trials by Sponsor Type 25

Prominent Sponsors 26

Top Companies Participating in Meniere Disease Therapeutics Clinical Trials 27

Prominent Drugs 28

Latest Clinical Trials News on Meniere Disease 29

May 21, 2015: Otonomy Reports Phase 2b Topline Data for OTO-104 in Meniere's Disease 29

Clinical Trial Profiles 30

Clinical Trial Overview of Top Companies 30

Otonomy, Inc. 30

Clinical Trial Overview of Otonomy, Inc. 30

Abbott Laboratories 31

Clinical Trial Overview of Abbott Laboratories 31

UMC Utrecht 32

Clinical Trial Overview of UMC Utrecht 32

Synphora AB 33

Clinical Trial Overview of Synphora AB 33

Rho, Inc. 34

Clinical Trial Overview of Rho, Inc. 34

Pfizer Inc. 35

Clinical Trial Overview of Pfizer Inc. 35

Lambda Therapeutic Research Ltd. 36

Clinical Trial Overview of Lambda Therapeutic Research Ltd. 36

Cromsource Srl 37

Clinical Trial Overview of Cromsource Srl 37

Buffalo ENT Specialists, LLP 38

Clinical Trial Overview of Buffalo ENT Specialists, LLP 38

Clinical Trial Overview of Top Institutes / Government 39

Tehran University of Medical Sciences 39

Clinical Trial Overview of Tehran University of Medical Sciences 39

Chi Mei Medical Center 40

Clinical Trial Overview of Chi Mei Medical Center 40

Gifu University 41

Clinical Trial Overview of Gifu University 41

House Research Institute 42

Clinical Trial Overview of House Research Institute 42

Kitasato University Oriental Medicine Research Center 43

Clinical Trial Overview of Kitasato University Oriental Medicine Research Center 43

Osaka University 44

Clinical Trial Overview of Osaka University 44

UMC Utrecht Holding BV 45

Clinical Trial Overview of UMC Utrecht Holding BV 45

Five Key Clinical Profiles 46

Appendix 67

Abbreviations 67

Definitions 67

Research Methodology 68

Secondary Research 68

About GlobalData 69

Contact Us 69

Disclaimer 69

Source 70

List of Figures

Meniere Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Meniere Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11

Meniere Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 17

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Meniere Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 19

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 20

Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25

Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

GlobalData Methodology 68

List of Tables

Meniere Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7

Meniere Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Meniere Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Meniere Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11

Meniere Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Meniere Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 14

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 15

Meniere Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 16

Proportion of Meniere Disease to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2015* 17

Meniere Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 18

Meniere Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 19

Meniere Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 20

Meniere Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 21

Meniere Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 22

Meniere Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 23

Meniere Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24

Meniere Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25

Meniere Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26

Meniere Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27

Meniere Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otonomy, Inc., 2015* 30

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 31

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht, 2015* 32

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Synphora AB, 2015* 33

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Rho, Inc., 2015* 34

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Lambda Therapeutic Research Ltd., 2015* 36

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cromsource Srl, 2015* 37

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Buffalo ENT Specialists, LLP, 2015* 38

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 39

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Chi Mei Medical Center, 2015* 40

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Gifu University, 2015* 41

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by House Research Institute, 2015* 42

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kitasato University Oriental Medicine Research Center, 2015* 43

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2015* 44

Meniere Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2015* 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Otonomy, Inc.

Abbott Laboratories

UMC Utrecht

Synphora AB

Rho, Inc.

Pfizer Inc.

Lambda Therapeutic Research Ltd.

Cromsource Srl

Buffalo ENT Specialists, LLP

Meniere Disease Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Meniere Disease, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com